Keyphrases
Glycemic Control
100%
Therapy Initiation
100%
Insulin Pump Therapy
100%
Type 1 Diabetes Onset
100%
Continuous Subcutaneous Insulin Infusion
100%
Type 1 Diabetes Mellitus (T1DM)
27%
Type I Diabetes
27%
Hemoglobin A1c (HbA1c)
18%
HbA1c Levels
18%
Severe Hypoglycemia
18%
Year of Diagnosis
18%
Multiple Daily Injection Therapy
18%
Medical Center
9%
Physiologic
9%
Between-group Difference
9%
Food Intake
9%
Physical Activity
9%
Glycated Hemoglobin
9%
Young Age
9%
Diabetes Duration
9%
Disease Treatment
9%
Added Benefit
9%
Retrospective Observational Study
9%
Tertiary Care
9%
Treatment-related
9%
Diabetes Management
9%
Early Disease
9%
Diabetic Ketoacidosis
9%
Healthcare Team
9%
Ketoacidosis
9%
Disease-related
9%
Blood Glucose Monitoring
9%
Patient Gender
9%
Long-term Glycaemic Control
9%
Insulin Release
9%
Infusion Use
9%
Diagnosis-related Groups
9%
Pump Therapy
9%
Medicine and Dentistry
Glycemic Control
100%
Insulin Dependent Diabetes Mellitus
100%
Insulin Pump
100%
Insulin Infusion
100%
Hemoglobin A1c
27%
Patient with Type 1 Diabetes
27%
Disease
18%
Diabetes
18%
Hypoglycemia
18%
Observational Study
9%
Physical Activity
9%
Insulin Release
9%
Tertiary Care
9%
Food Intake
9%
Mental Capacity
9%
Glycated Hemoglobin
9%
Flexibility
9%
Ketoacidosis
9%
Blood Glucose Monitoring
9%
Diabetic Ketoacidosis
9%
Infusion Therapy
9%
Nursing and Health Professions
Insulin Dependent Diabetes Mellitus
100%
Insulin Pump
100%
Insulin Infusion
100%
Hemoglobin A1c
27%
Patient with Type 1 Diabetes
27%
Disease
18%
Hypoglycemia
18%
Tertiary Health Care
9%
Glycosylated Hemoglobin
9%
Blood Glucose Monitoring
9%
Ketoacidosis
9%
Infusion Therapy
9%
Diabetic Ketoacidosis
9%